scispace - formally typeset
G

G. Prosdocimo

Publications -  8
Citations -  248

G. Prosdocimo is an academic researcher. The author has contributed to research in topics: Fluorescein angiography & Magnetic resonance imaging. The author has an hindex of 6, co-authored 7 publications receiving 230 citations.

Papers
More filters
Journal ArticleDOI

Posterior capsule opacification after phacoemulsification: silicone CeeOn Edge versus acrylate AcrySof intraocular lens.

TL;DR: Both the CeeOn Edge and AcrySof groups had a low incidence of PCO after an 18‐month follow‐up, and results confirm that IOLs with square truncated edges create a barrier effect at the optic edge, reducing the overall incidence ofPCO.
Journal ArticleDOI

Risk factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study.

TL;DR: In this paper, the authors evaluated corneal graft survival over a 5-year period and investigated whether factors related to the donor, eye bank practices, recipient, surgery, and postoperative course influenced the outcome.
Journal ArticleDOI

Acute bilateral vitreo-retinal hemorrhages following oxygen-ozone therapy for lumbar disk herniation

TL;DR: Retinal hemorrhages seem to be an uncommon but significant complication of intradiscal O(2)O(3) infiltration, and it is suggested that it should be carefully considered when recommending this procedure.
Journal ArticleDOI

Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea.

TL;DR: Analysis of KS by means of HPLC showed that in vitro cultured stromal keratocytes express and secrete more KS than keratinocytes, thus mirroring results observed in vivo, and expression of the CHST6 gene and of KS proteoglycans such as mimecan, lumican is limited toStromal Keratocytes.
Journal Article

Single-Session Photodynamic Therapy Combined with Intravitreal Bevacizumab for Retinal Angiomatous Proliferation

TL;DR: In this article, the authors evaluated the efficacy of single-session photodynamic therapy (PDT) combined with intravitreal bevacizumab (IVB) in the treatment of retinal angiomatous proliferation (RAP) in age-related macular degeneration.